AVEO Oncology
AVEO
#7099
Rank
NZ$0.90 B
Marketcap
NZ$25.96
Share price
0.00%
Change (1 day)
175.69%
Change (1 year)

Earnings for AVEO Oncology (AVEO)

Earnings in 2022 (TTM): -NZ$44.46 Million

According to AVEO Oncology 's latest financial reports the company's current earnings are NZ$94.31 Million. In 2021 the company made an earning of -NZ$92.34 Million a decrease over its 2020 earnings that were of -NZ$61.6 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for AVEO Oncology from 2009 to 2022

Annual earnings

Year Earnings Change
2022 (TTM) -NZ$44.46 Million-51.85%
2021 -NZ$92.34 Million49.9%
2020 -NZ$61.6 Million-479.04%
2019 NZ$16.25 M-276.17%
2018 -NZ$9.23 Million-91.79%
2017 -NZ$0.12 Billion142.38%
2016 -NZ$46.37 Million78.51%
2015 -NZ$25.98 Million-71.55%
2014 -NZ$91.3 Million-50.72%
2013 -NZ$0.19 Billion-4.88%
2012 -NZ$0.2 Billion-426.29%
2011 NZ$59.69 M-159.85%
2010 -NZ$99.75 Million35.33%
2009 -NZ$73.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
NZ$3.29 B-6,656.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
NZ$8.90 B-17,817.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Merrimack Pharmaceuticals
MACK
-NZ$3.92 Million-92.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.90 B-27,762.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$38.95 B-77,594.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$14.27 B-28,489.41%๐Ÿ‡บ๐Ÿ‡ธ USA